Literature DB >> 23807679

Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis.

Yonghua Niu1, Tairi Huang, Feng Lian, Fenghua Li.   

Abstract

The aim of this study is to determine the diagnostic accuracy of contrast-enhanced ultrasonography (CEUS) for diagnosis of small (≤ 2 cm in diameter) hepatocellular carcinoma (HCC) through a meta-analysis of published studies. A comprehensive literature search of PubMed, Embase, Web of Science, and China BioMedicine databases was conducted on articles published before 1 March 2013. Data from selected studies were pooled to yield summary sensitivity, specificity, positive and negative likelihood ratio (LR), diagnostic odds ratio (DOR), and receiver operating characteristic (SROC) curve. Statistical analyses were performed using Meta-Disc version 1.4 and STATA version 12.0 softwares. Fifteen studies were included with a total of 908 cirrhotic patients with 1,032 small hepatic nodules. All lesions were histologically confirmed through liver biopsies after CEUS. The pooled sensitivity was 0.81 (95% CI = 0.78-0.85); the pooled specificity was 0.86 (95% CI = 0.82-0.89). The pooled positive LR was 5.90 (95% CI = 3.90-8.94); the pooled negative LR was 0.20 (95% CI = 0.14-0.29). The pooled DOR was 37.07 (95% CI = 24.79-55.44). The area under the SROC curve was 0.93 (SE = 0.01). Meta-regression analysis showed that the number of lesions may be a major source of heterogeneity. No publication bias was detected in this meta-analysis. This meta-analysis indicates that CEUS is a useful diagnostic tool with high sensitivity and specificity for identifying small HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807679     DOI: 10.1007/s13277-013-0948-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

Review 1.  Early detection and curative treatment of early-stage hepatocellular carcinoma.

Authors:  Masatoshi Kudo
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

Review 2.  Reasons or excuses for avoiding meta-analysis in forest plots.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Hannah R Rothstein
Journal:  BMJ       Date:  2008-06-21

Review 3.  Understanding heterogeneity in meta-analysis: the role of meta-regression.

Authors:  W L Baker; C Michael White; J C Cappelleri; J Kluger; C I Coleman
Journal:  Int J Clin Pract       Date:  2009-10       Impact factor: 2.503

4.  Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  C Verslype; O Rosmorduc; P Rougier
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

5.  Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis.

Authors:  Limei Xie; Yang Guang; Hailong Ding; Ailu Cai; Ying Huang
Journal:  Ultrasound Med Biol       Date:  2011-04-30       Impact factor: 2.998

Review 6.  Epidemiology, risk factors and surveillance of hepatocellular carcinoma.

Authors:  G Cabibbo; A Craxì
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

7.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.

Authors:  Hyun-Jung Jang; Tae Kyoung Kim; Stephanie R Wilson
Journal:  Eur J Radiol       Date:  2008-10-01       Impact factor: 3.528

9.  Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.

Authors:  Hui-Xiong Xu; Xiao-Yan Xie; Ming-De Lu; Guang-Jian Liu; Zuo-Feng Xu; Yan-Lin Zheng; Jin-Yu Liang; Li-Da Chen
Journal:  J Clin Ultrasound       Date:  2008-06       Impact factor: 0.910

10.  Evaluating heterogeneity in cumulative meta-analyses.

Authors:  Elmer V Villanueva; Silva Zavarsek
Journal:  BMC Med Res Methodol       Date:  2004-07-13       Impact factor: 4.615

View more
  17 in total

1.  Diagnostic value of IMP3 in pancreatic cancer: a meta-analysis.

Authors:  Qianqian Wang; Tao Wang; Zhu Wang; Hong Zheng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.

Authors:  Lin Zhu; Yiling Liu; Guangyuan Chen
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 3.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

4.  Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Qianjing Hu; Yongchun Shen; Dan Xu; Tao Wang; Fuqiang Wen
Journal:  Tumour Biol       Date:  2014-03-08

5.  Local curative effect of MRI-guided radiofrequency ablation on small hepatocellular carcinoma.

Authors:  Zheng-Yu Lin; Qian-Qian Song; Jin Chen; Ren-Jun Wan; Hui Zheng; Zhong-Wu Chen; Yi-Ping Chen; Wang-Chun Hua
Journal:  Tumour Biol       Date:  2014-12-14

6.  High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.

Authors:  F Giangregorio; M Garolfi; E Mosconi; L Ricevuti; M G Debellis; M Mendozza; C Esposito; E Vigotti; D Cadei; D Abruzzese
Journal:  J Ultrasound       Date:  2022-10-13

Review 7.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

Review 8.  Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression.

Authors:  Ying Zhang; Kazushi Numata; Yuewu Du; Shin Maeda
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

Review 9.  Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.

Authors:  Kerstin Schütte; Christian Schulz; Peter Malfertheiner
Journal:  Gastrointest Tumors       Date:  2014-05-09

10.  Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.

Authors:  Diandian Li; Bo Wang; Hongyu Long; Fuqiang Wen
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.